EUVIMEDEUVIMED entdecken
Crossref

One step at a time: Melanocytic differentiation in fusion‐driven cutaneous neoplasms

Konstantinos Linos iD

Journal of Cutaneous Pathology · 2023

DOI: 10.1111/cup.14543 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cutaneous Pathology, 2023. Verfasst von Konstantinos Linos. Beteiligte Einrichtung: Department of Pathology & Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Kidney Neoplasms, Melanoma, Sarcoma, Clear Cell. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 12 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

As dermatopathologists, we routinely diagnose melanocytic nevi, melanomas, and occasionally melanocytomas in our daily clinical practice. However, it is now clearly established that the presence of melanocytic differentiation in a tumor does not necessarily indicate any of the aforementioned diagnoses. Tumors such as clear cell sarcoma, malignant melanotic nerve sheath tumor, PEComa, melanotic neuroectodermic tumor of infancy, and even certain translocation‐associated renal cell carcinomas all share the common characteristic of melanin synthesis. Over the past two decades, with the advent of molecular diagnostics, there has been an explosion of new data and discoveries in this field. Examples such as CRTC1::TRIM11 cutaneous tumors and MITF pathway‐activated melanocytic tumors ( ACTIN::MITF and MITF::CREM ) have been incorporated into the latest edition of the WHO classification of skin tumors (5th ed). In a recent issue, Alexandrescu et al. reported another case of a dermal/subcutaneous melanocytic tumor harboring a MITF::CREM1 translocation. In a separate paper within the current issue, Li et al. present a case of clear cell sarcoma with the rare EWSR1::CREM fusion, which had initially been misdiagnosed as melanoma with regional and distant metastases. We warmly welcome these two very interesting and high‐quality articles to our journal, and we eagerly anticipate what the future holds for this fascinating category of tumors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Renal CellKidney NeoplasmsMelanomaSarcoma, Clear CellSkin NeoplasmsHumansBiomarkers, TumorCell DifferentiationTripartite Motif ProteinsUbiquitin-Protein Ligases

Stichwörter der Autor:innen

CREMCRTC1MITFTRIM11clear cell sarcomamelanocytic

Substanzen

Biomarkers, TumorTRIM11 protein, humanTripartite Motif ProteinsUbiquitin-Protein Ligases

Autor:innen und Institutionen

  • Department of Pathology & Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.

ORCID-Profile: Konstantinos Linos

Zitieren

APA

Linos, K. (2023). One step at a time: Melanocytic differentiation in fusion‐driven cutaneous neoplasms. Journal of Cutaneous Pathology. https://doi.org/10.1111/cup.14543

Vancouver

Linos K. One step at a time: Melanocytic differentiation in fusion‐driven cutaneous neoplasms. Journal of Cutaneous Pathology. 2023. doi:10.1111/cup.14543

BibTeX
@article{Linos2023,
  author = {Linos, Konstantinos},
  title = {One step at a time: Melanocytic differentiation in fusion‐driven cutaneous neoplasms},
  journal = {Journal of Cutaneous Pathology},
  year = {2023},
  doi = {10.1111/cup.14543}
}
Kostenlos starten →